Hospital Readmission After HIPr Fracture. Impact of a Territorial Fracture Liason Service

Hip Fractures Clinical Trial

— FLSSantPau  

Official title:

Hospital Readmission After HIPr Fracture. Impact of a Territorial Fracture Liason Service

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT05266755
• Other study ID #: IIBSP-FLS-2021-114
• Status: Not yet recruiting
• Phase: N/A
• Start date: March 15, 2022
• Est. completion date: April 1, 2023

Study information

• Verified date: March 2022
• Source: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
• Contact: Jordi M Marcuello, Doctor
• Phone: 629315207
• Email: jmartinma[@]santpau.cat
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The International Osteoporosis Foundation (IOF) and the American Society for Bone Research and Mineral Metabolism recommend the creation and implementation of fracture coordination services (FLS) as the most efficient way to address the problem. FLS has emerged as a new clinical approach that uses coordinated, multidisciplinary care to improve post-fracture outcomes and reduce recurrent fractures. It is a multidisciplinary and protocolized care model that must guarantee:

1. Identify fragility fractures and people at risk for a fracture

2. Fracture risk assessment

3. Indication for treatment or referral

4. Improvement in therapeutic compliance

5. Reduce the risk of falls It is known that patients who have undergone a FLS model (vs no FLS), have lower mortality, lower risk of fracture, with a reduction of 35% and 56%, respectively, during two years of follow-up. One of the most important objectives of the FLS is the proper recognition and treatment of osteoporosis (OP) in patients with fragility fractures. A major problem is the lack of adherence to treatment for OP, and inclusion in an FLS program increases the prescription of bisphosphonates from 17.9% to 76%. In addition, a specific follow-up program means that 73% of patients followed by FLS continue to undergo anti-resorptive treatment after 2 years of having suffered a femur fracture.

Description:

Hypothesis After a femur fracture due to fragility, upon discharge from surgery at the Hospital de la Santa Creu i Sant Pau, including patients in a regional FLS program will make it possible to complete the study of the patient with fracture, improve adherence to treatment of OP (secondary prevention), and obtain better functional recovery.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 120
• Est. completion date: April 1, 2023
• Est. primary completion date: January 1, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 65 Years to 99 Years

Eligibility

Inclusion Criteria:

• All hip fractures older than 65 years

Exclusion Criteria:

• Politraumatic fractures

• Metastasic fractures

Related Conditions & MeSH terms

• Fractures, Bone
• Hip Fractures

Intervention

Other:
• Fracture Territorial Liaison Service afert a Hip fracture
Give a diferent than the current one way of follow up to the patients with hip fracture

Locations

Country	Name	City	State
Spain	Jordi Martin Marcuello	Barcelona	Catalunya

Sponsors (1)

Lead Sponsor	Collaborator
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Country where clinical trial is conducted

Spain, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of Deaths	% of Number of deaths after 1st year o follow up	1 year after discharge
Primary	Number of Falls	Number of Falls 1st year o follow up	1 year after discharge
Primary	Percentage of patients with adequated Osteoporotic treatment	Percentage of patients with adequated osteoporotic treatment	1 year after discharge
Secondary	Barthel at the end of follow up	Compare Barthel after hospital discharge with the end of follow up barthel. Minimum is 0 maximum is 100.	1 year after discharge